CardioDx Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:CardioDx Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7280
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CardioDx Inc (CardioDx) is a cardiovascular genomic diagnostics company. It undertakes the development of clinically validated tests in the areas of coronary artery disease, cardiac arrhythmias and heart failure. The company’s flagship product, Corus CAD gene expression test is used for assessing obstructive CAD (Coronary Artery Disease) in patients with chest pain. The company, along with its leading cardiologist’s conducts DISCERN (diagnostic investigation of sudden cardiac event risk) multi-center clinical study in the area of cardiac arrhythmias; and PREDICT trial to develop and validate gene expression tests for patients with symptoms suggestive of coronary artery disease. CardioDx is headquartered in Palo Alto, California, the US.

CardioDx Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CardioDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CardioDx Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
CardioDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CardioDx Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
CardioDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CardioDx Inc, Medical Equipment, Deal Details 10
Venture Financing 10
CardioDx Raises USD18 Million in Venture Financing 10
CardioDx Raises Additional USD7.3 Million in Series D Financing Round 11
CardioDx Raises USD5 Million in Series D Financing Round 12
CardioDx Raises USD14 Million in Extended Series DD Venture Financing 13
CardioDx Raises USD21 Million in Series D Financing 14
CardioDx Secures USD6 Million in Venture Funding 15
Cardiodx Raises US$58 Million In Series F Financing 16
CardioDx Secures USD30.5 Million in Venture Funding 19
Partnerships 20
CardioDx Enters Into Co-Marketing Agreement With Medison 20
CardioDx And Core Diagnostics Enter Into Co-Marketing Agreement For Corus CAD Diagnostic Test 21
Equity Offering 22
CardioDx Withdraws IPO 22
CardioDx Inc – Key Competitors 23
CardioDx Inc – Key Employees 24
CardioDx Inc – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
CardioDx Inc, Medical Equipment, Key Facts 2
CardioDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
CardioDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CardioDx Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
CardioDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CardioDx Inc, Deals By Market, 2012 to YTD 2018 8
CardioDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CardioDx Raises USD18 Million in Venture Financing 10
CardioDx Raises Additional USD7.3 Million in Series D Financing Round 11
CardioDx Raises USD5 Million in Series D Financing Round 12
CardioDx Raises USD14 Million in Extended Series DD Venture Financing 13
CardioDx Raises USD21 Million in Series D Financing 14
CardioDx Secures USD6 Million in Venture Funding 15
Cardiodx Raises US$58 Million In Series F Financing 16
CardioDx Secures USD30.5 Million in Venture Funding 19
CardioDx Enters Into Co-Marketing Agreement With Medison 20
CardioDx And Core Diagnostics Enter Into Co-Marketing Agreement For Corus CAD Diagnostic Test 21
CardioDx Withdraws IPO 22
CardioDx Inc, Key Competitors 23
CardioDx Inc, Key Employees 24

List of Figures
CardioDx Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
CardioDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
CardioDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
CardioDx Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
CardioDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CardioDx Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
CardioDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CardioDx Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[CardioDx Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Entegris Inc (ENTG):企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • Vivendi S.A.:戦略・SWOT・企業財務分析
    Vivendi S.A. - Strategy, SWOT and Corporate Finance Report Summary Vivendi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Mercury Systems Inc (MRCY):企業の財務・戦略的SWOT分析
    Summary Mercury Systems Inc (Mercury) is a technology company that develops defense electronic solutions. It offers products such as chassis and subsystems, solid state drives, memory, mixed-signal processing, mission computing and avionics, system in package, high density secure memory, FPGA digita …
  • Mears Group PLC (MER):企業の財務・戦略的SWOT分析
    Summary Mears Group PLC (Mears) is a housing and social care provider. The company offers repairs, rapid response and planned maintenance services for a portfolio of social homes. It provides housing services such as new homes, energy services, housing management, home improvement, branches, planned …
  • Bharti Infratel Ltd
    Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • KAZ Minerals PLC:企業のM&A・事業提携・投資動向
    KAZ Minerals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KAZ Minerals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Chronos Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Chronos Therapeutics Ltd (Chronos) is a research company that offers drug discovery and development services. The company offers research and development, drug discovery, lead optimization, preclinical efficacy, IND enabling, screening, pipeline development and clinical trial services. Its p …
  • Cytune Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Cytune Pharma SAS (Cytune) is a health care product developer that develops immunotherapeutic agents for the treatment of cancer and infectious diseases. The company’s product portfolio includes recombinant proteins and monoclonal antibodies. Its CYP0150 is a recombinant protein, which decre …
  • BrainScope Company Inc:医療機器:M&Aディール及び事業提携情報
    Summary BrainScope Company Inc (BrainScope) is a medical device company that offers medical neurotechnology products. The company develops and distributes non-invasive instruments for the treatment of traumatic brain injuries, moderate traumatic brain injury and mild traumatic brain injury. It provi …
  • Rubius Therapeutics Inc (RUBY):製薬・医療:M&Aディール及び事業提携情報
    Summary Rubius Therapeutics Inc (Rubius Therapeutics) is a biotechnology company that focuses on the development of medicines for the treatment of rare diseases, cancer and autoimmune diseases. The company through its rubius erythrocyte design (RED) platform engineer and culture Red Cell Therapeutic …
  • The Miyazaki Taiyo Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Miyazaki Taiyo Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Miyazaki Taiyo Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Revance Therapeutics Inc (RVNC):製薬・医療:M&Aディール及び事業提携情報
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Hang Lung Properties Limited:企業の戦略・SWOT・財務情報
    Hang Lung Properties Limited - Strategy, SWOT and Corporate Finance Report Summary Hang Lung Properties Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Rutherford Electric Membership Corp:企業の戦略的SWOT分析
    Rutherford Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Innergex Renewable Energy Inc (INE):企業の財務・戦略的SWOT分析
    Innergex Renewable Energy Inc (INE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Boston Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Boston Pharmaceuticals Inc (Boston Pharma) is a drug development company that develops new drugs for unmet needs. The company acquires and advances various drug candidates from investigational new drug application (IND) through Phase 2 including BOS161721, BOS172767, BOS173717, BOS172722, BO …
  • PIQUR Therapeutics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary PIQUR Therapeutics AG (PIQUR) is a developer of anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipeline products comprise PQR-309, PQR-620, PQR-530, PQR …
  • VINCI Energies:電力:M&Aディール及び事業提携情報
    Summary VINCI Energies S.A. (Vinci), a subsidiary of Vinci SA, is a provider of energy efficiency and renewable energy solutions. The company offers heating, ventilation and air conditioning, electric power, mechanical engineering and information and communications technologies. Vinci operates in mu …
  • AMAG Pharmaceuticals Inc:企業の戦略的SWOT分析
    AMAG Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Dynasil Corporation of America (DYSL)-医療機器分野:企業M&A・提携分析
    Summary Dynasil Corporation of America (Dynasil) is an electronic equipment company that develops and manufactures optics and photonics products. The company also offers optical detection and analysis technology and components. It provides products such as beamsplitters, diffraction gratings, infrar …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆